Approval · Notice of Compliance 2082 · 1999
LAMISIL: Notice of Compliance 2082
Issued March 19, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2082
- Date
- March 19, 1999
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New dosage form (gel)
- Therapeutic class
- Antifungal agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LAMISIL | 02239876 | Approved |
Medicinal ingredients
- TERBINAFINE 1 PER